AI Verdict
HCA has stronger fundamentals based on our AI analysis.
COR vs HCA Fundamental Comparison
| Metric | COR | HCA |
|---|---|---|
| Revenue | $85.9B | $75.6B |
| Net Income | $559.6M | $6.8B |
| Net Margin | 0.7% | 9.0% |
| ROE | 29.3% | N/A |
| ROA | 0.7% | 11.2% |
| Current Ratio | 0.92x | 0.97x |
| Debt/Equity | 4.15x | N/A |
| EPS | $2.87 | $28.33 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
COR vs HCA: Frequently Asked Questions
Is COR or HCA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HCA has stronger fundamentals. COR is rated SELL (74% confidence) while HCA is rated BUY (75% confidence). This is not investment advice.
How does COR compare to HCA fundamentally?
Cencora, Inc. has ROE of 29.3% vs HCA Healthcare, Inc.'s N/A. Net margins are 0.7% vs 9.0% respectively.
Which stock pays higher dividends, COR or HCA?
COR has a dividend yield of N/A or no dividend while HCA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in COR or HCA for long term?
For long-term investing, consider that COR has SELL rating with 74% confidence, while HCA has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about COR vs HCA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For COR vs HCA, the AI consensus favors HCA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.